Hypotron

Midodrine Hydrochloride, the active ingredient in Hypotron, is an Alpha-1 adrenergic agonist presented as an oral dosage form for oral use. It is employed to raise blood pressure in patients with orthostatic hypotension, helping to reduce dizziness and fainting episodes. It is indicated for adults who experience a significant drop in systolic blood pressure upon standing, a condition that can impair daily activities.

GNH USA supplies Hypotron as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, adhering to stringent quality standards and regulatory requirements across the EU and other markets.

Midodrine Hydrochloride is used to manage orthostatic hypotension, a disorder of autonomic blood pressure regulation.

- Orthostatic hypotension: raises standing systolic blood pressure and reduces dizziness or fainting. - Neurogenic orthostatic hypotension: improves vascular tone in patients with autonomic failure. - Postural hypotension: helps maintain blood pressure upon standing, supporting daily activities.

Common side effects are generally mild and related to its vasoconstrictive action.

Common Side Effects: - Supine hypertension: elevated blood pressure when lying down. - Piloerection: goose‑flesh skin reaction. - Pruritus: itching, often on the scalp. - Urinary retention: difficulty emptying the bladder. - Nausea: mild gastrointestinal upset. - Scalp tingling: transient paresthesia.

Serious or Rare Side Effects: - Severe hypertension: potentially dangerous rise in blood pressure. - Myocardial infarction: rare heart attack risk. - Arrhythmia: abnormal heart rhythm. - Ischemic stroke: rare cerebrovascular event. - Severe urinary retention requiring catheterisation. - Anaphylaxis: extremely rare allergic reaction.

Patients and prescribers should observe several safety measures when using Hypotron. - Monitor blood pressure: check both supine and standing values regularly. - Avoid in severe cardiac disease: risk of excessive hypertension. - Caution with renal impairment: dose adjustment may be needed. - Review concomitant antihypertensives: potential additive blood‑pressure effects. - Educate on supine hypertension: advise patients to avoid lying flat after dosing. - Store at room temperature: keep in the original pack, protect from moisture.

Midodrine Hydrochloride can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other vasopressors (e.g., phenylephrine): risk of severe hypertension. - Monoamine oxidase inhibitors: potential hypertensive crisis. - Clonidine withdrawal: unpredictable blood‑pressure changes.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance orthostatic blood‑pressure fluctuations. - Beta‑blockers: may blunt compensatory tachycardia. - Anticholinergic agents: may increase urinary retention risk.